Our current supply of tirzepatide API is available in scales ranging from 15 kg to 50 kg per month and constitutes our major peptide as of 2025. Our peptide unit is equipped with specialized peptide synthesis equipment and an analytical-preparatory high-performance liquid chromatography (HPLC) system, enabling precise and efficient API. Complemented by GMP-accredited manufacturing suites, we ensure that every product adheres to the highest quality and regulatory standards. We are committed to providing end-to-end solutions that accelerate the success of your drug products, with a focus on quality, innovation, and efficiency at every stage.